Condition

Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

ClinicalTrials.gov condition label

Clinical trials3

Recruiting2

Common interventions9

Lead sponsors shown3

Clinical trials

3 shown

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsNCT05269381 · 2022-03-31

RECRUITING

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid TumorsNCT04771520 · 2021-01-20

RECRUITING

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyNCT03707574 · 2019-07-16

COMPLETED

Common interventions

Biospecimen CollectionPROCEDURE2AvapritinibDRUG1BiopsyPROCEDURE1Computed TomographyPROCEDURE1CyclophosphamideDRUG1Magnetic Resonance ImagingPROCEDURE1Neoantigen Peptide VaccineBIOLOGICAL1PembrolizumabBIOLOGICAL1SargramostimBIOLOGICAL1

Leading sponsors

M.D. Anderson Cancer Center1Mayo Clinic1National Cancer Institute (NCI)1

Trial status mix

RECRUITING2

COMPLETED1

Phase mix

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.